The aim of this study was to determine whether plasma and red cell fatty acid levels were associated with cardiovascular disease, and whether any association was independent of other major risk factors. Over 1100 subjects were examined in a random sample survey of the general population (the Edinburgh Artery Study). Fatty acids were measured in three plasma fractions (triglyceride, cholesteryl ester and phospholipid) and in red cell phospholipids. Fatty acid levels in groups with cardiovascular disease (myocardial infarction (MI), angina and lower limb disease) were compared with a no disease group. In the cholesteryl ester and phospholipid fractions there were significantly lower levels of eicosapentaenoic acid in the MI group on univariate analysis (pϽ0.05), but not when adjusted for age, sex, smoking and systolic blood pressure using logistic regression. In the red cell fraction, alpha-linolenic acid was significantly lower in those with stroke (pϽ0.01) and lower limb disease (pϽ0.05). Linoleic acid was significantly raised in the triglyceride fraction in those with MI, probably reflecting recent dietary changes. There were significant increases in dihomo-gamma-linolenic acid in the phospholipid and red cell fractions in those with MI, and in the phospholipid fraction in the stroke group. These results do not support the hypothesis that n-6 fatty acids are protective against cardiovascular disease, although there may be some beneficial effects of the n-3 fatty acid, alpha-linolenic acid. Results from cross-sectional surveys must, however, be interpreted with caution because the presence of disease may affect dietary intake.
Introduction
Epidemiological evidence suggests that certain essential fatty acids are associated with a reduced risk of cardiovascular disease. Linoleic acid (LA) and alpha-linolenic acid (ALA) are the main dietary essential fatty acids (EFAs), which occur predominantly in vegetable oils, but fish oils are also an important source of eicosapentaenoic acid (EPA) (Figure 1 ).
An early indication that essential fatty acids may prevent atherosclerosis came from the finding that Greenland Eskimos had a low incidence of myocardial infarction, possibly due to their high dietary intake of fatty fish, containing mainly EPA. 1 Since then, a high concentration of fatty fish has also been associated with a lower incidence of cardiovascular disease in Canada, 2 and with lower mortality from heart disease in The Netherlands. 3 In Japan, where there is a high consumption of seafood rich in EPA and arachidonic acid (AA), there are lower than expected rates of smoking-related coronary heart disease. 4 Similarly, a Mediterranean diet, also high in n-3 fatty acids, is protective against heart disease. 5 It has been suggested that n-triglyceride 6 and low-density lipoprotein levels, 7 lowering blood viscosity 8 and increasing fibrinolytic activity. 9 Deficiencies of the n-6 fatty acid, linoleic acid, have also been associated with increased risk of coronary artery disease. [10] [11] [12] [13] Throughout Europe, levels of linoleic acid are inversely related to the gradient of coronary heart disease, 14 and in Scotland, men with coronary heart disease have lower than expected levels of adipose linoleic acid, 13 independent of other classical risk factors, including smoking. 15 It has also been suggested that low levels of several metabolites of both linoleic acid and alpha-linolenic acid may be more closely associated with the risk of coronary disease than the parent essential fatty acids themselves, particularly dihomo-gamma-linolenic acid (DGLA), arachidonic acid, eicosapentaenoic acid and docosahexaenoic acid. 12, 13, [15] [16] [17] [18] Linoleic acid is also known to reduce several factors associated with the development of atheroma, including LDLcholesterol 19 and platelet aggregability. 20 Despite the considerable evidence examining the role of essential fatty acids in coronary heart disease, relatively little work has been done on lower limb disease. This paper reports findings from a large population survey of cardiovascular disease, including peripheral arterial disease, in which fatty acid levels were measured in over 1100 subjects. The aim of this paper is therefore to determine whether there is any association between fatty acid levels and peripheral arterial disease, myocardial infarction and stroke, and whether any association is independent of other major risk factors. 
Methods

Study population
A population sample of 1156 men and women aged 60-80 years was examined cross-sectionally for cardiovascular disease and essential fatty acid levels. These individuals represent survivors from 1592 participants recruited to the Edinburgh Artery Study 5 years previously, with an attendance rate of 83.2%. Details of the study recruitment 21 and follow-up procedures 22 are given elsewhere. The study was approved by the Lothian Health Board Ethics Committee, and informed consent was obtained from each participant.
Identification of cardiovascular disease
Physical examination
Examinations were carried out by three specially trained nurses between November 1992 and March 1994. Subjects completed a self-administered questionnaire, including questions concerning new cardiovascular events, personal characteristics, the WHO angina and intermittent claudication questionnaires 23 and smoking history. After resting for 5 min in the supine position, the ankle/brachial systolic pressure index (ABPI) was recorded using a Hawksley random zero sphygmomanometer: brachial systolic and diastolic (Phase V) blood pressures were measured in the right arm; and ankle pressures were measured using a Sonicaid Doppler ultrasound probe in the posterior tibial arteries of both legs. Finally, 30 ml of venous blood was withdrawn for subsequent analysis of fatty acids.
Cardiovascular events
Information about the following cardiovascular events was obtained during the 5-year period prior to the examination: myocardial infarction, angina, stroke, transient ischaemic attacks, intermittent claudication, critical limb ischaemia, Vascular Medicine 1999; 4: 219-226 thrombo-embolism, vascular surgery, angioplasty and coronary artery bypass grafting. Criteria to define these events were adapted from the American Heart Association, 24 and an event was recorded only if these criteria were fulfilled. Details on non-fatal events were obtained from general practitioners, hospitals, the Information and Statistics Division of the Scottish Office Home and Health Department, and the subjects themselves. The Information and Statistics Division provided computer printouts of all hospital discharges occurring for subjects in Scotland. For those discharges with relevant ICD-9 codes (International Classification of Diseases, version 9), the medical records were investigated at the appropriate hospitals. Each participant also received an annual questionnaire enquiring about the development of the following conditions in the previous year: heart attack, stroke, chest and leg pain, loss of power in arms or legs, and hardening of the arteries.
Fatty acid analysis
Fatty acid levels were estimated on all 1156 subjects who attended for examination, but two subjects were excluded from all analyses because the sum of one of the fractions exceeded 100. Blood was withdrawn into EDTA tubes, and plasma separated and stored at −40°C. Red cells were washed with saline and then also stored. Plasma triglyceride, cholesteryl ester and phospholipid fractions were separated by thin layer chromatography. Each fraction was methylated, and the fatty acid methyl esters measured by gas chromatography; the analysis was performed by Scotia Pharmaceuticals, Stirling, UK. Results were expressed as the concentration of each fatty acid in milligrams per 100 mg in the lipid fraction as previously described. 25 Levels of the following fatty acids were determined: n- ; mead acid (20:3n-9); saturated and monounsaturated fatty acids -palmitic acid (16:0), oleic acid (18:1), stearic acid (18:0).
In the statistical analysis, some fatty acids were grouped to reflect differences in metabolism: essential fatty acids indicating deficiency (20:2n-6, 20:3n-9 and 22:5n-6); the ratio of DGLA/AA reflecting the degree of conversion at the delta-5-desaturase step; the ratio of LA/DGLA and AA, reflecting the degree of conversion at the delta-6-desaturase step; and the ratio of non-essential to total essential fatty acids.
Data analysis
Information on the questionnaire and recording forms was checked by the clinic staff, coded and entered onto a DBASE IV database. Error rates were determined by dual entry of all data, and any discrepancies were checked by reference to the original records. All analyses were crosssectional.
The ABPI for each leg was calculated by dividing the ankle pressure by the brachial pressure. The lower of the indices obtained for the two legs was used as the measure of disease severity in the subsequent data analysis. The mean ABPI of the study population at baseline was compared with the mean ABPI at follow-up using a paired ttest.
Cardiovascular disease was divided into four groups: (1) myocardial infarction (evidence of either: at least two of the following -ECG changes, WHO questionnaire or recall of myocardial infarction (MI); or criteria fulfilled for MI in the 5 years prior to examination); (2) stroke (recall or stroke criteria fulfilled); (3) intermittent claudication (WHO questionnaire evidence, or major asymptomatic disease or an ABPI р0.7); and (4) no disease (none of the previous criteria, or evidence of angina).
The distribution of fatty acids was skewed and therefore the results are presented as geometric means. Baseline comparisons between disease and no disease groups were performed using the Mann-Whitney test (age, sex and blood pressure) and the chi-squared test (smoking). Fatty acid levels between groups were compared using the Mann-Whitney test on transformed values. Logistic regression analyses were performed on all fatty acid levels which differed significantly between the disease and no disease groups, adjusting for age, sex, smoking and systolic blood pressure. Because the fatty acids were log transformed, the odds ratios are expressed as one unit increase on a log scale.
Results
Characteristics of disease groups
There were small but statistically significant differences in age among the groups; those with no disease were slightly younger ( Table 1 ). There was a greater proportion of men in the disease groups compared with the no disease group, but this reached statistical significance for the myocardial infarction (MI) group only (60% men compared with 48% in the no disease group, pϽ0.01). There were significantly more ex-smokers in the myocardial infarction group compared with those with no disease, but significantly fewer never and current smokers (pϽ0.01). There were signifi-Vascular Medicine 1999; 4: 219-226 cantly more current and ex-smokers, and fewer never smokers in the lower limb group (pϽ0.01). Systolic blood pressure was significantly higher in all disease groups compared with the no disease category, particularly in the stroke group, but there were no significant differences in diastolic pressure.
Fatty acid differences
Fatty acid levels in the four fractions were examined separately (Tables 2-5 ). In each fraction, the three disease groups were compared with the no disease group. In the plasma triglyceride (PTG) fraction, there were no statistically significant differences in either the stroke or lower limb groups compared with those with no disease, but the trends were similar to those in the myocardial infarction group ( Table 2 ). There were significantly lower levels of oleic acid (pϽ0.05) and total non-essential fatty acids (pϽ0.01) in the MI group, but significantly higher levels of linoleic acid (pϽ0.01) and total EFAs (pϽ0.001). Calculated ratios suggested that deficiency of essential fatty acids was significantly less in the myocardial infarction group compared with the those with no disease. The MI group also showed significantly higher DGLA/AA (pϽ0.05) and LA/(DGLA and AA) (pϽ0.01), and lower non EFA/total EFA ratios (pϽ0.001) compared with those with no disease. These differences were still present after adjusting for age, sex, smoking and systolic blood pressure (Table 6 ).
In the plasma cholesteryl ester (PCE) fraction (Table 3) , and in all subsequent fractions, levels of non-essential fatty acids were similar in all disease groups. In the MI group, there were significantly lower EPA levels (pϽ0.05), but after adjusting for age, sex and smoking, fatty acids showed no significant effect on risk of MI (Table 6 ). In both the MI and lower limb groups, EFAs indicating deficiency were significantly lower (pϽ0.01). There were no significant differences in those with stroke compared with the no disease group.
In the plasma phospholipid (PPL) fraction (Table 4) , EPA was again significantly lower in the MI group (pϽ0.05), but this relationship did not persist on logistic regression (Table 6 ). Also in the MI group, DGLA was significantly greater (pϽ0.01) and the DGLA/AA ratio was also significantly increased compared with those with no disease (pϽ0.01). In those with stroke, DGLA was also significantly raised (pϽ0.05), and the LA/(DGLA and AA) ratio was significantly lower (pϽ0.05). The DGLA/AA ratio was also significantly higher in the lower limb group (pϽ0.05). All of these relationships, except EPA in the MI group, were unaffected by logistic regression (Tables 6  and 7 ).
In the red cell phospholipid (RCPL) fraction (Table 5) , DGLA was again significantly higher in the MI group (pϽ0.05), and the DGLA/AA ratio was significantly increased (pϽ0.05). ALA levels were significantly lower in those with stroke (pϽ0.01), and lower limb disease (pϽ0.05). DGLA was also significantly higher in those with lower limb disease (pϽ0.05). Using logistic regression, the significant effect of an increased DGLA/AA ratio in those with MI was not found after adjusting for smoking, and the raised DGLA in those with lower limb disease was non-significant on adjusting for systolic blood pressure (Tables 6 and 7) . Red cell ALA, however, remained significantly reduced in those with lower limb disease and stroke after adjustment for smoking and blood pressure.
Discussion
The Edinburgh Artery Study was designed primarily to study the epidemiology of peripheral arterial disease, but indicators of stroke and coronary disease were also included. There were relatively few subjects with stroke, and the small sample size probably explains why fewer findings showed statistical significance in this group. There was a relatively large number of subjects with lower limb disease, but this includes major asymptomatic disease identified by the ABPI and a reactive hyperaemia test. The large proportion of original subjects that attended for examination suggests that this was a representative sample, and as follow-up continues, the value of these fatty acids in predicting future cardiovascular events will be determined.
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Characteristics of disease groups
The characteristics of disease groups reflect known risk factors for cardiovascular disease including increasing age, male sex, smoking and blood pressure. 26 There were more ex-smokers than current smokers in the myocardial infarction group, possibly because these individuals had all suffered an acute event and were advised to stop. In contrast, there were more current smokers in the lower limb and stroke groups, but this was statistically significant for the lower limb group only, probably because of the small sample size in the stroke group. Systolic blood pressure was significantly raised in those with stroke compared with no disease, however, despite the relatively small number of subjects, which supports other studies demonstrating that this is the most important risk factor for stroke. 27
Fatty acid differences
The fatty acid composition of the plasma triglyceride fraction primarily reflects recent dietary intake, and is therefore the least reliable measure of long-term nutritional habits. Fatty acid levels in this fraction were generally similar in those with disease and no disease, with the exception of linoleic acid which was higher in all disease groups, and significantly increased in those with myocardial infraction. A possible explanation for this difference could be an increased tendency for individuals to consume vegetable oils following dietary advice after a clinical event. This would also explain the significantly lower levels of nonessential fatty acids in the MI group. A relatively recent widespread adoption of this dietary behaviour, showing reduced linoleic acid levels in those with atherosclerosis, might explain the discrepancy with other studies. [10] [11] [12] [13] Dietary intake of linoleic acid has been shown to be reduced in smokers, 15, 28 and as there were more smokers in the disease Vascular Medicine 1999; 4: 219-226 groups, this would have been expected to show an effect. The lack of any deficit in essential fatty acids in those with MI was confirmed by a lower level of fatty acids indicating deficiency. The fatty acid content of phospholipid and cholesteryl ester fractions is more independent of recent intake, and is probably a better indicator of the longer-term composition of dietary fats. 29 An alternative indicator of long-term intake is adipose tissue fatty acids, but this method provides information mostly about long-term nutritional supply of linoleic acid, and provides relatively little information with respect to subsequent metabolism because levels of metabolites are very low in adipose tissue. 30 These fractions also showed raised linoleic acid levels in the disease groups, but these were not statistically significant. Further down the elevated. There was, however, some suggestion that n-3 fatty acids were lower in those with disease: EPA was significantly reduced in those with MI (PPL and plasma cholesteryl (PCE) fractions), and ALA was significantly lower in those with stroke and lower limb disease (red cell fraction). On adjusting the odds ratios for age, sex and smoking, however, EPA showed no differences in the MI group, although ALA remained significantly lower in those with stroke and lower limb disease. These findings therefore do not confirm other studies, which have shown n-6 fatty acids to protect against coronary disease, but suggest that the n-3 fatty acid ALA may be protective. One previous report, however, comparing patients with lower limb disease with healthy controls, also demonstrated no differences in n-6 fatty acids, and showed lower levels of the n-3 fatty acids EPA and DHA which were not significant after adjusting for smoking. 31 Recent evidence from Israel, where intake of linoleic acid is about 10% higher than other European countries, has also suggested that excessive intakes of linoleic acid may not be desirable. 32 However, this must be set against the large amount of previous evidence suggesting that, within a population, linoleic acid is protective, particularly in diabetes. 10, [13] [14] [15] 33, 34 It is also important to distinguish between different fatty acids within a class because some may be protective while others may be harmful. Further research is therefore required before further dietary advice is widely recommended.
